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Thymus serrulatus, an endemic plant of Ethiopia, is traditionally used to cure various
diseases and as a food ingredient. In the Ethiopian folk medicine, the decoction is orally
taken as a remedy to treat diabetes and high blood pressure. The purpose of the present
study was to evaluate the antioxidant and antihyperglycemic effects of the aqueous extract
and of the essential oil of Thymus serrulatus. The chemical composition of the aqueous
extract was determined by LC-MS and the essential oil was characterized by GC-MS
analysis. Radical scavenging assays, namely scavenging of 2,2-diphenyl-1-picrylhydrazyl
(DPPH•), hydroxyl (•OH), and nitric oxide (•NO), were used as a first approach to screen the
potential antioxidant abilities of the samples. Alpha-amylase and α-glucosidase inhibitory
studies were also employed to evaluate the in vitro antihyperglycemic potential of the plant.
The in vivo blood glucose lowering effect of the extracts was assessed using hypoglycemic
activity and the oral glucose tolerance test in normal and in streptozotocin induced diabetic
mice. When compared to the aqueous extract, the essential oil showed superior radical
scavenging activity, particularly for •NO, as well as greater inhibitory potency against
α-amylase and α-glucosidase (IC50  0.01 mg/ml and 0.11 mg/ml, respectively). Both
tested samples showed a statistically significant antihyperglycemic effect. The aqueous
extract at 600mg/kg exerted maximum antihyperglycemic activity (44.14%), followed by
the essential oil (30.82%). Body weight and glucose tolerance parameters were also
improved by the samples both in normal and diabetic mice. The findings of this study
support the hypothesis that aqueous extract and essential oil of T. serrulatus are promising
therapeutic agents.
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INTRODUCTION
Diabetes mellitus (DM), more simply called diabetes, is an
endocrine disorder caused by a defect in the pancreas that
prevents the production of insulin or its inefficient use by
the body, resulting in hyperglycemia that, over time, leads to
severe health complications (American Diabetes Association,
2009; Toelsie et al., 2013). DM is a worldwide growing
epidemic disorder, with 424.9 million people affected in 2017
and an estimated 48% increase in the number of diabetic
individuals by the year 2045 (European Society of Cardiology,
2019).
Chronic hyperglycemic patients live with a high risk of long-term
macro- and microvascular complications, such as cardiovascular
diseases, nephropathy, retinopathy, and neuropathy (Paul et al.,
2020). The ability of free radicals to damage biomolecules is
presently accepted to play a key role in late diabetic
complications (Asmat et al., 2016). In this context, antioxidant
therapy may be considered as one of the important therapeutic
strategies in diabetes management (Johansen et al., 2005).
The plant materials being employed as traditional medicines
are considered promising sources of new drugs to counteract
many diseases, including DM (Doan et al., 2018). In addition to
that, plants offer a source of dietary ingredients that affect human
physiological functions in order to treat diabetes (Shori, 2015).
The genus Thymus (Lamiaceae) includes about 350 species,
mostly with a high content of essential oil (Ghasemi Pirbalouti
et al., 2015; Salehi et al., 2019). This is mostly distributed in
Europe, Asia, and North Africa (Zarshenas and Krenn, 2015) and
the vast majority of Thymus species are found in and around
Mediterranean areas (Niculae et al., 2019). Two native species of
thymus, namely Thymus serrulatus and Thymus schimperi, are
found in Ethiopia and both are locally known as Tosign
(Amharic) and Tesni/Thasne (Tigrigna) (Damtie and
Mekonnen, 2015).
Thymus serrulatus Hochst. Ex Benth is a much-branched
perennial subshrub endemic to Ethiopian highlands
(2000–4000 m. a.s.l.) of Semien Shoa, Tigray, and Wollo
(Damtie and Mekonnen, 2015; Melka et al., 2016). It is
restricted to the northern parts of the country and is reported
to be found in Alamata and Ofla (Tigray), Yilmana Densa (West
Gojjam), and Tarmaber (North Shewa) (Damtie et al., 2017). In
turn, T. serrulatus is found in different parts of Ethiopia. This
specie is commonly used to flavor tea, coffee, and different kinds
of stew (Asfaw et al., 2000). Traditionally, the fresh or dried whole
parts, leaves, or flowers of the plant are crushed and drunk as a tea
to treat different illnesses, including diabetes, high blood pressure,
general pain syndrome, abdominal pain, intestinal parasites, and
renal disease (Meresa et al., 2017). It is also used for the treatment
of headache, earache, and liver disease (Melka et al., 2016). The
essential oil of T. serrulatus is also used for medicinal purposes as
antiseptic, antifungal, and vermifuge properties (Asfaw et al.,
2000). The bioactive potential of the plant is supported by
previous experimental studies, which include antihelimenthic,
antibacterial, fungicidal (Damtie and Mokonen, 2015), diuretic
(Melka et al., 2016), vasodilatory (Geleta et al., 2015), and
hepatoprotective (Damtie et al., 2017) activity.
Distinct studies previously reported in vivo/animal assays with
thyme species (Li et al., 2019). In addition, the profile of phenolic
compounds (Afonso et al., 2020) and of essential oils (Tohidi
et al., 2019) from Thymus species originating from different parts
of the world have been reported. Still, to our knowledge, there is
no report concerning the phytochemical composition and
antidiabetic effect of T. serrulatus. Therefore, this study
evaluated the chemical composition, antioxidant potential, and
the antihyperglycemic effects of a decoction and of essential oils
from T. serrulatus origin.
MATERIALS AND METHODS
Chemicals
The phenolic compounds salvianolic acid B, ferulic acid,
apigenin-O-glucoside, eriodictyol-7-O-glucoside, quercetin-7-
O-glalactoside, luteolin-7-O-glucoside, and rosmarinic acid
(obtained from Extrasynthese, Genay Cedex, France) were
used as standards for the phenolic characterization of the
aqueous extract. Thymol 99% (Sigma Aldrich, Germany) was
also used as a standard reference to confirm the identity of the
compound in the essential oil. Glibenclamide (Alfa aesar, Great
Britain), acarbose (Bayer Pharma AG, Leverkusen, Germany),
and quercetin (Sigma- Aldrich, St. Louis, MO, United States)
were used as reference standard for the in vivo antidiabetic
activity, in vitro digestive enzyme inhibitory activity, and
radical scavenging activity tests of the samples, respectively.
Plant Materials
The sample of T. serrulatus aerial parts was collected during
flowering season from Emba Alaje mountain area, Emba Alaje
District of South Tigray, Ethiopia (located at 13° 00′ North
latitude and 39° 20′East longitude) in the month October
2018. The plant was authenticated by Getinet Masresha
(taxonomist) at the Department of Biology, University of
Gondar, Ethiopia. A voucher specimen (TH-001/2011) was
placed for reference in the University of Gondar’s herbarium.
Preparation of the Aqueous Extract
The aqueous extract was prepared by decoction, according to
Afonso et al. (2017), with adaptations. Aerial parts T. serrulatus
were shed dried and then powdered. The powdered plant material
(20 g) was mixed with distilled water (400 ml) and then boiled for
15 min, left to cool for 5 min, and filtered through Whatman
grade 1 filter paper, using a pressurized suction filtration system.
Upon concentration in vacuo at 40°C, the filtrate was defatted
with n-hexane (1:1 v/v). The resulting aqueous extract was freeze-
dried, sealed, and kept in a refrigerator for further use. A fresh
stock solution was prepared for the experiment whenever
required.
Extraction of the Essential Oil
The fresh aerial parts (250 g) of T. serrulatus were cut into small
pieces and distilled (hydro-distillation) for 3 h in Clevenger-type
apparatus. The process was repeated 11 times to get enough oil.
The essential oil obtained was dried with anhydrous sodium
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sulfate and kept in closed vials at 4°C in a refrigerator (Asfaw
et al., 2000). The percent yield of the obtained essential oil was
calculated based on the weight of the fresh plant material (v/w).
Phytochemical Characterization of the
Aqueous Extract
The phenolic compounds in T. serrulatus aqueous extract were
identified by UHPLC-DAD-ESI-MSn analysis, performed on a
Ultimate 3000 (Dionex Co., Sunnyvale, CA, United States)
apparatus equipped with an ultimate 3000 Diode Array
Detector (Dionex Co.), and coupled to a mass spectrometer,
according to the method previously described by Pereira et al.
(2018). The chromatographic apparatus was composed of a
quaternary pump, an autosampler, a photodiode-array
detector, and an automatic thermostatic column compartment.
The column used had a 100 mm length, 2.1 mm i. d., 1.9 µm
particle diameter, and end-capped Hypersil Gold C18 column
(Thermo Scientific, Waltham, MA, United States), and its
temperature was maintained at 30°C. The solvent system used
to analyze the sample include water acidified with 0.1% formic
acid (v/v) (solvent A) and acetonitrile (solvent B). The elution was
carried out in binary gradient by gradually increasing the amount
of solvent B; from 10–20% (over 6 min), from 20–25% (12 min),
from 25–34% (30 min) and increased up to 100% at 37 min
maintaining for 3 min, finally returning to the initial
conditions at 40 min. The flow rate used was 0.2 ml/min−1.
The UV–Vis spectral data for all peaks accumulated in the
range 200–600 nm and the chromatographic profiles were
recorded at 280, 320, and 340 nm. The mass spectrometer
used was a Thermo LTQ XL (Thermo Scientific, San Jose, CA,
United States) ion trap MS, equipped with an ESI source with
Thermo Xcalibur Qual Browser software. The instrument was
operated in negative-ion mode and the full scan covered the mass
range fromm/z 100 to 2000. Nitrogen above 99% purity was used
and the gas pressure was 520 kPa (75 psi). ESI needle voltage set at
5.00 kV and an ESI capillary temperature of 275°C. CID–MS/MS
andMSn experiments were simultaneously acquired for precursor
ions using helium as the collision gas with collision energy of
25–35 arbitrary units.
The major compounds in the aqueous extract were quantified
using the external standard method by peak integration with the
exact or structurally related compounds.
Phytochemical Analysis of the Essential Oil
The essential oil composition of T. serrulatus was analyzed by
GC-MS according to the adapted method of Tirillini et al. (2008).
For the analysis, a gas chromatograph (Agilent 7820A) equipped
with a FID and a capillary column (fused silica DB-5, 30 m ×
0.25 mm i. d., 0.25 μm film thickness), coupled with a mass
spectrometer (Agilent 5977B) was used. 50 µL of the oil was
diluted in 1.5 ml of methanol in order to improve the separation
of peaks and the injection volume was 1 µL. The oven conditions
were set initially at 60°C and continued for 3 min and then the
temperature was increased at 4°C/min to 300°C and held for
15 min. The injector and detector were operated at 250°C, the
flow rate of the carrier gas (helium) was adjusted to 1 ml/min and
a split ratio of 1:10 was applied. GC-MS system was operated in
the EI mode at 70 eV, in the mass range from an m/z of
30–500 amu.
The identification of compounds was carried out by matching
their mass spectra with mass spectral library of NIST (version 2.2)
and the identity of each component was confirmed by comparing
their retention indices (generated by Chemstation software)
relative to the C6-C22 n-alkanes with those from the literature
(Asfaw et al., 2000; Tirillini et al., 2008; Mancini et al., 2015).
Thymol was co-eluted as a standard reference to additionally
confirm its identity. The percentage composition of the
components was obtained by the peak areas normalization
method.
Preparation of Samples for the In Vitro
Experiments
For in vitro assays, the aqueous extract was dissolved in methanol
(Sigma-Aldrich®, Milan, Italy) in the concentration of 0.25 mg/
ml, after being vortexed (Vortex, Phoenix AP56, Araraquara, São
Paulo, Brazil) for 5 min and centrifuged at 4000 rpm at 0°C for
20 min (Eppendorf 5810 R) and the essential oil was diluted in the
methanol in the concentration 0.33 mg/ml. The stock solution
concentration of quercetin was 2 mg/ml.
Antioxidant Activity
Diphenyl-1-picrylhydrazyl Radical DPPH• Scavenging
Activity
The effect of T. serrulatus aqueous extract and essential oil against
DPPH radical was determined following the method adopted by
Vinholes et al. (2017). In this assay, the sample (25 μL) solution
(or methanol, in the case of blank) and 0.6 mM DPPH solution
(250 μL) were mixed in a 96-well microplate. Quercetin was used
as a positive control. After shaking the microplates, the mixture
was incubated in dark for 30 min and subsequently measured on
a plate reader (Spectra Max 190) at a wavelength of 515 nm. The
results were calculated as inhibition percentage (%I).
Hydroxyl Radical (•OH) Scavenging Activity
The ability of the samples to scavenge the hydroxyl radical was
determined according to the method described by Vinholes et al.
(2017) with adaptations. Each test sample (25 μL) was reacted by
mixing with 110 μL of iron sulfate heptahydrate solution (8 mM,
prepared in EDTA-Na 20 μM), 50 μL of hydrogen peroxide
solution (7 mM) and 74 μL of salicylic acid solution (3 mM).
Quercetin was used as positive control. After shaking, the
microplates were incubated at 37°C for 30 min and the
absorbance was read at 515 nm. The results were expressed as
inhibition percentage (% I).
Nitric Oxide Radical (•NO) Scavenging Activity
The nitric oxide radical scavenging ability of the T. serrulatus
aqueous extract and essential oil was determined according to the
method described by Vinholes et al. (2011). The samples (50 µL)
and sodium nitroprusside (50 μL, 20 mM) were added to a 96-
well plate and incubated under the effect of light for 60 min at
room temperature. Subsequently, 2% phosphoric acid solution
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(50 µL) and Griess reagent (50 µL) were added to the mixture and
further incubated for 10 min at room temperature in the dark and
the absorbance wasmeasured on amicro plate reader (SpectraMax
190), at a wavelength of 562 nm. Quercetin was used as standard.
The results were calculated as inhibition percentage (%I).
In Vitro Blood Glucose Lowering Effect
Inhibition of α-Amylase Activity
The activity of T. serrulatus aqueous extract and essential oil
against the α-amylase enzyme was assessed using the procedure
described by Satoh et al. (2015) with some adaptations. Each
extract (15 μL) was mixed with phosphate buffer (50 μL, pH 7.0)
and the α-amylase enzyme (12.5 μL, 241.71 U 62 ml−1), followed
by incubation at 37°C for 5 min. The soluble starch as a substrate
(62.5 μL) was added to initiate the reaction, and further incubated
at 37°C for 15 min. The reaction was stopped by adding 1 M
hydrochloric acid (12.5 μL) to the reaction mixture. Twenty-
five μL of the iodine solution (25 μL, 0.005 M) and potassium
iodide (0.005 M) was added for color formation. Acarbose was
used as a positive control. The absorbance reading was done on
polystyrene microplates containing 96 wells (Spectra Max 190-
Molecular Devices) at a wavelength of 690 nm. The α-amylase
enzyme inhibitory activity of the samples was expressed as IC50
(mg/ml).
Inhibition of α-Glucosidase Activity
The inhibition of the α-glucosidase enzyme was determined
according to the method described by Vinholes et al. (2011),
with some adaptations. The enzymatic samples (10 μL) were added
in p-nitrophenyl-α-D-glycopyranosidium substrate (50 μL,
3.25mM) (diluted in pH 7.0 phosphate buffer) solution. The
enzyme (50 μL, 9.37 U mL−1 diluted in phosphate buffer, pH
7.0) was then added in the mixture to start the reaction
followed by incubation of the mixture at 37°C for 10min.
Acarbose was used as a positive control. The absorbance
reading was done on polystyrene microplates containing 96
wells in a Spectra Max-Molecular Devices plate reader and was
read at a wavelength of 405 nm, immediately after the end of the
reaction. The results of inhibitory activity of α-glucosidase enzyme
were expressed as IC50.
In Vivo Blood Glucose Lowering Effect
Preparation of Animals
In this study, healthy albino mice (20–30 g), after random selection,
were housed in animal cages each containing groups of six mice with
natural night-daytime (12-h light/dark cycle) exposure and at room
temperature. The mice were provided standard pellets and tap water
ad libitum. During the experiments, the mice were fasted overnight
(12–14 h) but allowed free access to tap water. The in vivo study was
approved by the Health Research Ethics Review Committee
(ERC1550/2018), College of Health Sciences, Mekelle University
and all the procedures involving animals were conducted to the
internationally accepted guidelines.
Acute Oral Toxicity Test
Acute oral toxicity was performed according to OECD
(Organization for Economic Co-operation and Development)
guidelines 425. Albino mice of female sex selected by random
sampling were fasted for 3–4 h prior to dosing with free access
to water. First, 2000 mg/kg dose, dissolved in 2% tween 80,
was administered orally to a single mouse for each of the
test samples. The mice were then observed for physical or
behavioral changes for 24 h with special attention during
the first 4 h. Mice were given access to food after 2 h of
dosing. After survival of the administered mice for 24 h, four
additional mice (for each sample) were administered the same
amount of the aqueous extract/essential oil under the same
conditions. For any possible toxic effect of the sample, the
mice were closely observed in the first 4 h and then at regular
intervals up to 14 days.
Hypoglycemic Effect on Normoglycemic Mice
In this method, overnight fasted mice of both sexes with
normal blood glucose levels (BGL) were divided into eight
groups (n  6). The positive control group received standard
antidiabetic drug (glibenclamide 10 mg/kg), while the negative
control group received the vehicle [2% tween 80 (10 ml/kg)],
and the test groups were administered with the aqueous
extract of 150 mg/kg, 300 mg/kg, and 600 mg/kg; and essential
oil of 150 mg/kg, 300 mg/kg, and 600 mg/kg of T. serrulatus as per
body weight of the mice.
To assess the hypoglycemic effect of the test substances,
whole blood samples from the control and test groups of mice
were drawn immediately before (0 h) and after 1, 3, and 6 h
following administration of standard drug and test samples,
by tail snip method. BGL was measured using a glucometer.
Blood samples were taken at least three times and average value
was determined. The hypoglycemic effects of the test samples
were compared with the BGLs of the control groups (Sah et al.,
2011).
Oral Glucose Tolerance Test in Normoglycemic Mice
The oral glucose tolerance test was performed according to
the procedure described by Lanjhiyana et al. (2011). Overnight
fasted mice were divided into nine groups of six mice in
each group (n  6). Group 1 received 10 ml/kg of 2% tween
80 and served as a normal control group and Group 2 received
2 g/kg of glucose (negative control). Groups 3, 4, and 5 received
aqueous extract of T. serrulatus at doses of 150, 300, and
600 mg/kg body weight, and groups 6, 7, and 8 were given
essential oil at doses of 150, 300, and 600 mg/kg body weight.
Group 9 received glibenclamide, 10 mg/kg, and served as a
positive control group. Thereafter, a glucose load (2 g/kg body
weight) was given to each mouse, except the normal control
group, exactly after 30 min post administration of the test
samples, standard drug, or vehicle.
Blood glucose profile of each mouse was measured at five time
points: immediately prior to dosing (0 min), 30, 60, 90, and
120 min after administration of glucose in order to determine
their BGLs. Blood samples from eachmouse were drawn from tail
vein, using tail snip method, three to four times and the average
blood glucose values were taken. The BGLs were measured using
a glucometer. The area under the blood glucose concentration
curve (AUC) of each group was determined by plotting BGL
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against a time graph, and it was used to evaluate the overall
percentage reduction in post glucose load hyperglycemia.
Antihyperglycemic Activity on Streptozotocin Induced
Diabetic Mice
Hyperglycemia was induced in overnight fasted mice by injecting
streptozotocin (STZ) (55 mg/kg in 0.1 M citrate buffer, pH 4.5)
intraperitoneally a single time (Srinivasan and Ramarao, 2007).
The changes in BGL and body weight were noted regularly. After
three days, mice with fasting blood glucose (FBG) greater than
200 mg/dl were considered diabetic and were used for the
antihyperglycemic study.
The antihyperglycemic activity of T. serrulatus aqueous extract
and essential oil was performed according to the method
described by Kabbaoui et al. (2016). The mice were equally
divided and randomly assigned into nine groups of six mice
(n  6) each: Group 1: healthy mice received the vehicle (2%
tween 80, 10 ml/kg) and served as normal control group. Group
2: diabetic mice received a daily oral dose of 2% tween 80
(10 ml/kg), served as diabetic control group. Groups 3, 4, and
5: diabetic mice received a daily oral dose of 150, 300, and
600 mg/kg aqueous extract, respectively. Groups 6, 7, and 8:
diabetic mice received a daily oral dose of 150, 300, and
600 mg/kg of the essential oil respectively. Group 9: diabetic
mice received a daily oral dose of 10 mg/kg of the standard drug
glibenclamide and served as a positive control group. The test
samples, standard drug, and vehicle were started 3 days after
induction of diabetes and administered orally on a once daily
basis for 21 days using oral gavage.
Antihyperglycemic effect and body weight change were
evaluated by estimating the FBG levels and weight on days 0,
7, 14, and 21.
STATISTICAL ANALYSIS
The results in this study are expressed as mean ± SEM. The
in vitro antioxidant and blood glucose lowering values were
computed using Graph Pad Prism version 8 for Windows. The
in vivo data were analyzed using SPSS version 25 by means of
ANOVA to differentiate between means of all parameters and
the source of significant differences was determined by
applying Tukey’s post-hoc tests with multiple comparisons.
The results were considered significant (*) when p-value was
less than 0.05.
RESULTS
Phenolic Profile of the Aqueous Extract
The extraction yield of T. serrulatus aqueous extract was 11.4%
(2.28 g). Overall, its LC-MS analysis allowed the identification of
distinct phenolic compounds, being this particularly rich in
caffeic acid derivatives and salvianolic acids (Figure 1 and
Table 1). Among them, the two compounds eluted in peaks
19 and 22 were assigned to two isomers of salvianolic acid K, as
they exhibited the main [M-H]− ion at m/z 555 in MS spectrum
and the major product ions atm/z at 493 and 359 inMS2 analysis.
Notably, these isomers represented almost half (90 mg/g of the
extract) of the total quantified phenolic compounds (194.1 ±
15.9 mg/g of the extract). In addition, salvianolic acid B (TR
27.6 min, MW 718), the derivative of salvianolic acid F (TR 15.0
and 16.9 min, MW 376) and salvianolic acid A (TR 34.3 min, MW
494), appeared in moderate amounts. In detail, salvianolic acid B
(UVmax at 287 and 330 nm) presented m/z at 717 and the
fragmentation pattern with successive losses of 198 u
(danshensu) or 180 u (caffeic acid) units. Salvianolic acid A
produced a base peak at m/z 295 by the loss of 198 u (danshesu)
and other ions characteristics to this salvianolic acid fragmentation.
Rosmarinic acid (MW 360), a well-known dimer of caffeic
acid characteristic from Thymus plants, and its derivatives
overall represented about 15% of the total phenolics. This
compound was eluted in peak 18, which showed the [M−
H]− ion at m/z 359 and the product ions at m/z 161, 179,
197, 223 in MS2. Also, two other rosmarinic acid derivatives
were found in moderate amounts in the extract. These were
eluted in peaks 16 and 17, being characterized by [M− H]− ions
at m/z 521 and 403, respectively, and the presence of a major
product ion at m/z 359.
Flavones, namely, isoscutellarein, luteolin, and apigenin
glycosides were also representative phenolic constituents of the
extract, accounting for 16%, 10% and 3% of the total phenolic
content of the extract, respectively. Among these, isoscutellarein-
O-glucuronide (TR 27.0 min) was assigned due the UVmax at 268
and 337 nm and the m/z 461→285 consistent with the loss of a
glucuronyl moiety (−176 u). In a similar way, the fragment ion at
m/z 285 and the UVmax at 254, 264 and 345 nm, compatible with
luteolin, and the main ion [M-H]− at m/z, 461 allowed the
identification of luteolin-O-glucuronide (TR 21.3 min, MW
462), eluted in peak 15. Peak 6 with UVmax compatible with
apigenin (271, 333 nm) showed a molecular ion at m/z 593 and
typical C-glycosyl fragments atm/z 473, 503 and 383, allowing the
identification of apigenin di-C-glucoside.
Chemical Composition of the Essential Oil
The fresh erial parts of T. serrulatus after hydro-distillation
yielded 0.9% (24.75 ml) of essential oil, which was characterized
by a pale yellowish and a spicy odor. GC-MS analysis of the
essential oil revealed 22 components, representing about 99.92%
FIGURE 1 | LC-MS Chromatographic profile of T. serrulatus aqueous
extract.
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of the total detected constituents. The essential oil was mostly
composed of thymol (56.24%), carvacrol (15.44%), p-cymene
(9.39%), γ-terpinene (9.34%), carvacrol methyl ether (2.77%),
and β-myrcene (2.26%). Other components were present in
amounts less than 2% (Figure 2).
The composition of the essential oil is summarized in Table 2.
For easier comparison and speculating the intended activities of
the oil, the components were categorized into five classes of
phytochemicals, which were monoterpene hydrocarbons,
oxygenated monoterpenes, sesquiterpene hydrocarbons,
phenolic compounds, and other components. Accordingly, the
essential oil of T. serrulatus was mainly composed of phenolic
monoterpenes (71.68%) followed by monoterpene hydrocarbons
(23.25%).
In Vitro Antioxidant Activity
The antioxidant potential of the essential oil and aqueous extract
were determined on the basis of their scavenging activity of the
free radicals, namely against DPPH•, •OH and •NO. As presented
inTable 3, the essential oil and the aqueous extract were both able
to eliminate the DPPH and OH radicals, with higher percentages
of inhibition for the DPPH•. Curiously, essential oil was able to
partially scavenge •NO (approximately 35%), while no such
ability was registered for the aqueous extract and quercetin.
In Vitro Blood Glucose Lowering Effect
The essential oil was also more potent than the aqueous extract in
regard to the ability to inhibit α-amylase and α-glycosidase
enzymes. Also, both the aqueous extract and essential oil were
more effective than the drug acarbose against the enzyme
α-glycosidase. Moreover, the essential oil was five times
more potent than acarbose against the enzyme α-amylase
(Table 4).
In Vivo Blood Glucose Lowering Effect
Acute Toxicity Effect
The results of the acute oral toxicity indicated nomortality during
the 14 days follow-up. The findings suggested that both the
aqueous extract and essential oil are safe as no observable
adverse effects were found at the maximum dose 2000 mg/kg
body weight.
Hypoglycemic Effect
The effects of aqueous extract and essential oil of T. serrulatus on
FBG level in normoglycemic mice is shown in Table 5. At the
lowest dose (150 mg/kg), no significant decrease in blood glucose
level was observed in both tested samples. Unlike the essential
oil, which did not show any hypoglycemic property at all dose
levels, the aqueous extract (at 600 mg/kg) showed statistically
TABLE 1 | Phenolic compounds of T. serrulatus aqueous extracts determined by UHPLC-DAD-ESI-MSn.
NP TR (min) λMax (nm) [H–M]− MS/MS fragments
(m/z)
Probable compound Phenolic content
(mg/g)/% composition
1 1.7 206 191 111, 173 Quinic acid D
2 3.5 280 197 179, 73, 153 Danshensu 6.4 ± 0.9/3.3
3 3.7 279 571 509, 553, 237 Yunnaneic acid E 1.7 ± 0.4/0.88
4 9.0 292, 324 367 193, 191, 173 Feruloylquinic acid 1.3 ± 0.1/0.67
5 13.4 284 387 207, 163, 369 HydroxyJasm acid-O-hexoside D
6 14.6 271, 333 593 473, 503, 353, 383, 575 Apigenin di-C-glucoside 5.3 ± 0.4/2.73
7 15.0 290, 324sh 375 313, 269, 179, 135 Salvianolic acid F derivative 12.2 ± 1.7/6.29
8 16.0 283 449 287 Eriodictyol-O-hexoside 0.4 ± 0.1/0.21
9 16.9 287, 318sh 375 313, 269, 179, 135 Salvianolic acid F derivative 8.4 ± 0.7/4.33
10 17.4 282, 341 477 301, 299, 277, 191 Quercetin glucuronide 1.9 ± 0.2/0.98
11 17.7 281, 341 463 301 Quercetin-O-hexoside 2.1 ± 0.3/1.08
12 18.4 287, 329 553 491, 357, 399, 535 Salvianolic acid C derivative D
13 18.6 242, 260sh, 341 447 285 Luteolin-7-O-glucoside 2.5 ± 0.3/1.29
14 21.1 254, 267sh, 341 593 285 Luteolin-O-diglucoside 1.4 ± 0.2/0.72
15 21.3 254, 264sh, 345 461 285 Luteolin-O-glucuronide 17.3 ± 1.5/8.91
16 23.0 292sh, 308 521 359, 179, 197, 161 Rosmarinic acid hexoside 2.9 ± 0.2/1.49
17 25.5 287sh, 318 403 367, 385, 359, 313, 223 Rosmarinic acid derivative 2.1 ± 0.3/1.08
18 26.1 290sh, 328 359 161, 179, 197, 223, 133, 123 Rosmarinic acid 19.4 ± 1.5/9.99
19 26.9 287, 326sh 555 493, 359, 401, 537 Salvianolic acid K (isomer 1) 53.8 ± 2.9/27.72
20 27.0 268, 337 461 285 Isoscutellarein-O-glucuronide 31.3 ± 3.3/16.13
21 27.6 287, 330sh 717 519, 357, 555, 475 Salvianolic acid B 22.7 ± 1.8/11.7
22 27.9 287, 332sh 555 493, 359, 195, 179 Salvianolic acid K (isomer 2) 37.1 ± 2.7/19.11
23 30.1 252, 266, 344 591 531, 549, 285 Luteolin acetyl dipentoside 1.5 ± 0.2/0.77
24 31.1 287sh, 326 373 179, 161, 135, 197, 329, 355 Methyl rosmarinate 1.3 ± 0.1/0.67
25 32.1 284sh, 340 537 493, 515, 519, 357, 297, 179 Caffeoyl RA (isomer1) D
26 32.6 287sh, 326 537 493, 515, 359, 375, 357 Caffeoyl RA (isomer2) 1.4 ± 0.1/0.72
27 33.1 284sh, 341 537 493, 519, 515, 357, 339, 179 Caffeoyl RA (isomer3) D
28 33.4 287sh, 328 537 493, 519, 357, 438, 339, 197 Caffeoyl RA (isomer4) D
29 34.3 287, 332sh 493 359, 357, 313, 161, 295 Salvianolic acid A 4.7 ± 0.5/2.42
Total quantified phenolic content (mg/g) 194.1 ± 15.9
Values expressed as mg/g of extract; NP, Number of peak; D, Detected; TR, Retention time; RA, Rosmarinic acid, sh, shoulder.
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significant (p < 0.01) reduction in blood glucose level starting
from the 3rd h of administration as compared to the negative
control. After 6 h of administration, a statistically significant
(p < 0.001) reduction in blood glucose level was observed at
300 mg/kg of the aqueous extract. Moreover, the effect of
300 mg/kg aqueous extract (22.53%) was comparable with the
effect of the standard antidiabetic drug glibenclamide (22.82%)
in reducing the blood glucose level. Also, a statistically
significant (p < 0.001) decrease in the blood glucose level of
the positive control group was observed after 1 h of the
glibenclamide’s administration.
Oral Glucose Tolerance Test
The essential oil and water extract both showed statistically
significant (p < 0.001) suppression on BGL at all dose levels
starting from 30 min of administration of glucose as compared to
the negative control group administered with the vehicle (2%
tween 80, 10 ml/kg). Except for the normal control, the remaining
groups of mice exhibited a peak BGL 30 min after glucose load,
which was followed by a decrease over time to the pre-prandial
level (Figure 3).
The AUCs of glucose concentration in groups treated with T.
serrulatus aqueous extract, essential oil, and glibenclamide, were
significantly reduced by 36.99% (600 mg/kg), 47.19%
(300 mg/kg) and 60.45% (10 mg/kg) respectively, as compared
to the negative control group. The essential oil of T. serrulatus at
all dose levels produced plasma glucose levels significantly lower
than those of the aqueous extract at 30, 60, and 120 min after the
glucose administration in which the AUC during the OGTT was
significantly decreased by 41.35%, 47.19%, and 46.51% at 150,
300, and 600 mg/kg dose levels, respectively.
Antihyperglycemic Activity on Streptozotocin-Induced
Diabetic Mice
In the three-week treatment course, the fasting blood glucose
level of the mice were measured once a week as shown in
Table 6. There was no significant difference observed in
the fasting blood glucose level between the standard and test
groups before initiating the treatment. At the dose of
600 mg/kg, the groups that received standard drug and the
test substances showed statistically significant variations in
their FBG levels within the first week of treatment (p < 0.01
and p < 0.001, for the aqueous extract and essential oil
respectively). Furthermore, at the end of the second week,
the test groups that received 600 mg/kg of both aqueous
extract and essential oil (p < 0.001) and 300 mg/kg of the
essential oil (p < 0.05) showed significantly different FBG
levels at the end of the second week. On day 21, the test
groups that received 150 mg/kg (p < 0.05) and 300 mg/kg
(p < 0.001) of the aqueous extract also showed a statistically
significant reduction in their FBG levels.
The aqueous extract and essential oil at the highest dose level
(600 mg/kg) exerted maximum antihyperglycemic activity
(44.14%) and 30.82% respectively. The extract and essential oil
revealed a dose and time dependent antihyperglycemic effect.
Effect on Body Weight Changes
In this study, the STZ-induced untreated diabetic group showed
19.97% loss in body weight and the normal control group showed
a 4.96% increase during the treatment period. In addition to
the diabetic group, the group of mice treated with 150 mg/kg
of both of the test substances produced substantial reductions
in their body weight as compared to the normal mice. The
FIGURE 2 | GC-MS chromatographic profile of the essential oil of T. serrulatus.
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body weight of diabetic mice receiving glibenclamide and those
treated with 600 mg/kg of the aqueous extract and essential oil of
T. serrulatus showed no significant reduction over the
experimental time. A dose dependent improvement in the
body weight parameter of mice was observed during the
experiment (Table 7).
DISCUSSION
As the pharmacological activities of different plant extracts are
closely associated to their bioactive compounds, the chemical
compositions of the aqueous extract and essential oil of T.
serrulatus were determined. The aqueous extract of T.
serrulatus was shown to be rich in caffeic acid derivatives (e.g.,
rosmarinic acid) and salvianolic acids, the latter formed by
danshensu linked to caffeic acid moieties (Ma et al., 2019).
This finding is in agreement with aqueous decoction of T.
carnosus in which salvianolic acid K (19.7 mg/g from
42.92 mg/g total phenolics) and salvanolic acid A isomers
(16.91 mg/g) constituted the major phenolic content (Martins-
Gomes et al., 2018). Even though it is known that Thymus species
are rich in rosmarinic acid (Pereira and Cardoso, 2013; Afonso
et al., 2017), this was clearly less representative (15%) in T.
serrulatus aqueous extract. These differences in phytochemical
contents can depend considerably on extrinsic and intrinsic
TABLE 2 | Chemical composition of the essential oil extracted from the aerial parts of T. serrulatus.
Peak No Compound name TR (min.) Ri % Area Identification
1 α-Thujene 6.176 931 0.75 1.2
2 α-Pinene 6.374 937 0.14 1.2
3 3-Octanone 7.945 986 0.07 1.2
4 β-Myrcene 8.092 991 2.26 1.2
5 α-Phellandrene 8.531 1003 0.09 1.2
6 α-Terpinene 8.929 1017 0.83 1.2
7 p-Cymene 9.201 1022 9.39 1.2
8 D-sylvestrene 9.348 1027 0.15 1.2
9 (Z)-β-ocimene 9.652 1038 0.14 1.2
10 (E)-β-ocimene 9.997 1049 0.17 1.2
11 γ-Terpenene 10.384 1060 9.34 1.2
12 Linalool 11.787 1099 0.35 1.2
13 Terpinen-4-ol 14.520 1177 0.33 1.2
14 Thymol methyl ether 16.520 1235 0.11 1.2
15 Carvacrol methyl ether 16.844 1244 2.77 1.2
16 Thymol 18.572 1291 56.24 1,2,3
17 Carvacrol 18.855 1299 15.44 1.2
18 Thymol acetate 20.540 1355 0.58 1.2
19 Carvacrol acetate 21.147 1371 0.20 1.2
20 (E)-caryophyllene 22.674 1419 0.31 1.2
21 Germacrene D 24.592 1481 0.07 1.2
22 β-Bisabolene 25.409 1509 0.26 1.2






Identification method: 1, comparison of the Kovats retention indices with published data; 2, comparison of mass spectra with those listed in the NIST 2.2; 3, co-injection with authentic
compound.
TABLE 3 | Antioxidant activity of Thymus serrulatus aqueous extract and
essential oil.
Sample Radical capture (%)
•DPPH •OH •NO
TSEO 94.51 ± 0.08 51.35 ± 0.59 34.89 ± 11.88
TSAE 93.60 ± 0.03 48.89 ± 1.29 ND
Quercetin 92.98 ± 0.38 ND ND
Results expressed as the mean of % inhibition ± standard deviation. TSEO, Thymus




NO, nitric oxide radical;
•
DPPH, 2,2-diphenyl-1-picrylhydrazyl radical; ND, not
detected.
TABLE 4 | Inhibitory ability (IC50, mg/mL) of Thymus serrulatus aqueous extract
and essential oil against the digestive enzymes α-glucosidase and α-amylase.
Sample IC50 value (mg/ml)
α-amylase α-glucosidase
TSEO 0.01 ± 0.00 0.11 ± 0.01
TSAE 24.47 ± 0.29 2.47 ± 0.45
Acarbose 0.05 ± 0.02 16.88 ± 10.69
Results expressed as mean ± standard deviation. TSEO, Thymus serrulatus essential oil;
TSAE, Thymus serrulatus aqueous extract.
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factors including plant growth, harvest phases, storage, soil, and
climatic conditions (Shekarchi et al., 2012). Additionally,
isoscutellarein-O-glucuronide (16%) and luteolin-O-
glucuronide (10%) were the most prevalent among the other
flavone glycosides. These findings are in agreement with previous
reported data that showed O-glucuronide derivatives of luteolin
and other flavone glycosides have also been detected in different
Thymus species in significant amounts (Pereira et al., 2013a;
Pereira and Cardoso, 2013; Afonso et al., 2017; Afonso et al.,
2018).
The principal constituents of the essential oil were the
phenolic monoterpene isomers thymol (56.24%) and carvacrol
TABLE 5 | Hypoglycemic effects of the aqueous extract and essential oil of T. serrulatus in normoglycemic mice.
Treatment groups Fasting blood glucose concentration (mg/dl) % Change in FBG
(hr. 0–6)0 h 1 h 3 h 6 h
1 (negative control) 85.67 ± 0.80 81.17 ± 0.79 75.00 ± 1.13 73.33 ± 0.95 −14.40%
2 (TSAE 150 mg/kg) 85.50 ± 1.20 79.67 ± 0.95 70.33 ± 2.40 77.67 ± 0.92 −9.16%
3 (TSAE 300 mg/kg) 84.33 ± 1.23 84.17 ± 2.52 71.33 ± 2.29 65.33 ± 2.32*** −22.53%
4 (TSAE 600 mg/kg) 76.17 ± 0.87 78.00 ± 0.89 67.83 ± 0.60* 66.67 ± 0.88** −12.46%
5 (TSEO 150 mg/kg) 75.83 ± 0.31 82.17 ± 0.48 77.00 ± 0.37 81.00 ± 0.63 +6.82%
6 (TSEO 300 mg/kg) 83.83 ± 0.48 84.00 ± 0.45 76.17 ± 0.95 79.33 ± 0.56* −5.37%
7 (TSEO 600 mg/kg) 77.33 ± 1.02 76.50 ± 1.02 74.17 ± 1.08 75.17 ± 1.05 −2.79%
8 (GB 10 mg/kg) 82.50 ± 0.67 71.00 ± 0.58*** 65.83 ± 0.95*** 63.67 ± 0.42*** −22.82%
TSAE, aqueous extract of T. serrulatus, TSEO: essential oil of T. serrulatus, GB, Glibenclamide. Each value is presented as mean ± standard error of the mean (M ± SEM), n  6, *p < 0.05,
**p < 0.01, ***p < 0.001, *, **, *** statistical significance as compared to the negative control group, “+” percent increase in blood glucose level, “−” percent decrease in blood glucose level.
FIGURE 3 | Effects of the aqueous extract and essential oil on OGTT in normoglycemic mice: change in BGL (mg/dl) at different time intervals.
TABLE 6 | Effects of aqueous extract and essential oil of T. serrulatus on FBG level (mg/dl) in STZ induced diabetic mice.
Treatment groups Fasting blood glucose level (mg/dl) % Change in BGL
(day 0–21)Day 0 Day 7 Day 14 Day 21
1 (normal control) 97.33 ± 1.15 107.83 ± 1.33 101.67 ± 1.96 91.17 ± 0.95 −6.33%
2 (diabetic control) 271.67 ± 2.73 281.00 ± 5.01 268.17 ± 5.28 270.69 ± 6.42 −0.36%
3 (TSAE 150 mg/kg) 292.83 ± 2.20 291.17 ± 5.13 274.50 ± 4.46 249.83 ± 5.08* −14.68%
4 (TSAE 300 mg/kg) 284.33 ± 2.09 261.50 ± 4.87 251.83 ± 5.70 228.83 ± 6.82*** −19.52%
5 (TSAE 600 mg/kg) 294.17 ± 2.40 253.00 ± 5.46** 251.83 ± 4.99*** 164.33 ± 4.68*** −44.14%
6 (TSEO 150 mg/kg) 281.67 ± 3.13 278.00 ± 6.59 263.83 ± 6.45 254.00 ± 4.82 −9.82%
7 (TSEO 300 mg/kg) 289.00 ± 2.33 274.83 ± 4.30 237.67 ± 12.75* 226.17 ± 5.01*** −21.74%
8 (TSEO 600 mg/kg) 256.83 ± 3.36 243.00 ± 5.98*** 194.67 ± 4.19*** 177.67 ± 4.33*** −30.82%
9 (GB 10 mg/kg) 288.00 ± 5.08 180.33 ± 4.67*** 140.83 ± 6.90*** 112.83 ± 5.42*** −60.82%
TSAE, aqueous extract of T. serrulatus, TSEO: essential oil of T. serrulatus, GB, glibenclamide. Each value is presented as mean ± standard error of the mean (M ± SEM), n  6, *p < 0.05,
**p < 0.01, ***p < 0.001 *, **, *** statistical significance as compared to the negative control group given 2% tween 80 10 mg/kg, “−” percent decrease in blood glucose level.
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(15.44%). The findings are in line with a previous study showing
that the percent composition of the essential oils of the same plant
collected from Ofla and Alamata (South Tigray) were dominated
by thymol 49.6 and 65.6% respectively, but the findings differ
from those collected from Yilma Densa (West Gojjam, Amhara)
that constituted 80.8% carvacrol (Damtie et al., 2018). This
suggests that the variations in chemical composition of
essential oil can be due to differences in geographic and
climatic conditions (Asfaw et al., 2000). The essential oil
revealed a high amount of thymol therefore it can be classified
as thymol chemotype oil (Tirillini et al., 2008). This finding is in
agreement with an earlier study which indicated that the essential
oils of T. serrulatus belong to the thymol chemotype (Asfaw et al.,
2000; Tirillini et al., 2008; Damtie et al., 2017).
Studies show that the increased level of free radicals in the
human body is believed to be involved in the pathogenesis of
diabetes (Pitocco et al., 2013; Asmat et al., 2016). Thus, the
scavenging of these reactive oxygen and nitrogen species is
considered to be an effective measure to reduce oxidative stress
(Zhang et al., 2015). Thus, phytochemicals with antioxidant
properties could play an important role in the prevention and
treatment of diabetes (Lin et al., 2016). In this study, both the
aqueous extract and the essential oil showed strong radical
scavenging activities in the DPPH assay (%I values of 93.60 ±
0.03% and 94.51 ± 0.08%, respectively) as compared to the
other assays. Dessalegn and co-researchers also observed strong
scavenging effects by various solvent fractions of another thyme
specie endemic to Ethiopia (T. schimperi) against DPPH radicals
(92.2 ± 0.4% to 96.2 ± 1.2%) (Dessalegn et al., 2015).
The free radical scavenging activity of the aqueous extract
could be due to the higher content of polyphenolic components
like phenolic acids (especially caffeic acid derivatives, mainly
salvianolic acids and rosmarinic acid) (Pereira et al., 2013b) and
flavones (Catarino et al., 2015). In fact, these classes of
phytochemicals have strong antioxidant potential, which are
positively correlated with DPPH• scavenging activity (Wang
et al., 2019). On the other hand, the antioxidant capacity of
the essential oil might be related to its high content of the
phenolic monoterpene thymol. This is consistent with the
work of Kulisic and coworkers, who reported a high
antioxidant activity for the T. vulgaris essential oil, which is a
thymol chemotype oil (Kulisic et al., 2005). The results of this
research support the idea that thymol is a stronger antioxidant
than carvacrol, due to the greater steric hindering effects of the
phenolic group of the latter (Gedikoğlu et al., 2019). It is known
that any imbalance between free radicals and antioxidants leads
to the condition known as “oxidative stress” that results in the
development of a pathological condition in the body, including
diabetes. However, please note that even widely used as a fast and
reliable parameter to evaluate the general radical scavenging
activity of plant extracts (Ullah et al., 2016), in vitro assays
lack biological relevance, which must be established through in
vivo studies.
The anti-hyperglycemic effects of T. serrulatus extracts to
substantially reduce the elevated levels of blood glucose may
be an essential trigger for the development of normal homeostasis
during diabetes and its associated complications. Therefore, both
in vitro (α-amylase and α-glucosidase inhibitory assays) and in
vivo methods were employed to evaluate the antihyperglycemic
potential of the plant.
In the hypoglycemic study, we observed that the aqueous
extract, at a dose of 300 mg/kg and 600 mg/kg, significantly
lowered BGL compared to negative control in normal mice.
Contrary to our results, Shewasinad et al. (2018) reported that
the administration of a methanolic leaf extract of T. serpyllum to
mice caused no significant hypoglycemic effects in mice at all
doses. However, the acute oral administration of aqueous extract of
T. serpyllum leaves (at the dose of 500 mg/kg) showed significant
hypoglycemic effect on normoglycemic mice (Alamgeer et al.,
2016), which indicates that the effect might be due to the polar
phytochemicals present in the aqueous fraction (Issa and Hussen
Bule, 2015). Notably, the tested doses of T. serrulatus essential oil
showed no considerable hypoglycemic effect, suggesting that the
mechanism of antidiabetic action of the essential oil might differ
from that of the aqueous extract and of the standard drug
glibenclamide, which acts by stimulating the pancreatic β-cells
to secrete insulin (Tian et al., 1998).
The oral glucose tolerance test, also referred to as the glucose
tolerance test, measures the body’s ability to metabolize glucose
or clear it out of the bloodstream. The aqueous extract, essential
oil, and glibenclamide significantly reduced BGL level in mice by
36.99% (600 mg/kg), 47.19% (300 mg/kg), and 60.45%
TABLE 7 | Effects of aqueous extract and essential oil of T. serrulatus on body weight in STZ induced diabetic mice.
Treatment group Body weight of mice (g) % Change in body
weightDay 0 Day 7 Day 14 Day 21
1 (Normal control) 27.20 ± 1.14 26.73 ± 0.90 27.47 ± 0.91 28.55 ± 1.10 +4.96%
2 (Diabetic control) 24.78 ± 0.81 23.52 ± 0.43 21.80 ± 0.80 19.83 ± 0.42 −19.97%
3 (TSAE 150 mg/kg) 24.82 ± 0.83 23.85 ± 2.07 22.50 ± 0.68 21.08 ± 0.70 −15.05%
4 (TSAE 300 mg/kg) 26.75 ± 1.84 25.22 ± 1.54 24.15 ± 1.89 24.13 ± 0.87 −9.78%
5 (TSAE 600 mg/kg) 24.70 ± 0.61 24.27 ± 0.35 23.78 ± 0.49 24.22 ± 1.10 −1.96%
6 (TSEO 150 mg/kg) 26.12 ± 1.57 24.77 ± 1.92 24.17 ± 1.06 21.30 ± 0.38 −18.44%
7 (TSEO 300 mg/kg) 24.55 ± 1.57 22.55 ± 1.25 22.20 ± 0.58 22.75 ± 0.64 −7.33%
8 (TSEO 600 mg/kg) 23.90 ± 0.38 22.42 ± 0.54 22.92 ± 0.83 23.27 ± 0.66 −2.65%
9 (GB 10 mg/kg) 25.35 ± 1.68 24.45 ± 0.63 24.27 ± 0.39 25.03 ± 1.50 −1.25%
TSAE, aqueous extract of T. serrulatus, TSEO, essential oil of T. serrulatus, GB, Glibenclamide. Each value is presented asmean ± standard error of themean (M ± SEM), n  6, “+” percent
increase in body weight of mice, “−” percent decrease in body weight of mice.
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(10 mg/kg), respectively, as compared to the negative control
group. The significant reduction in the BGL registered in the
treated groups suggests that both the test substances elicited an
increase in glucose utilization and glucose tolerance by the body
tissues in mice, which indicates an improved glucose homeostasis
(Kabbaoui et al., 2016).
The effect of the relative long-term effect of T. serrulatus on
BGL was evaluated using STZ-induced diabetic mice. STZ is a
diabetogenic agent used in study on rodents (Wu et al., 2015;
Radenković et al., 2016) that destructs the pancreatic β-cells,
resulting in insufficient insulin secretion. STZ-induced diabetes
is reported to resemble the human DM, which is manifested
by hyperglycemia, glycosuria, polyphagia, polydipsia,
hypercholesterolemia, and body weight loss, which was also
observed in the experimentally induced animals in our study
(Hammeso et al., 2019).
The aqueous extract at the dose of 600 mg/kg was found to
have maximum antihyperglycemic activity (44.14%), followed by
the essential oil (30.82%) at the same dose level. This may be
explained by the fact that, the test samples are known to exhibit
their maximum potential effect at the highest dosage with time
against STZ induced diabetes (Rajendiran et al., 2019). Also, these
findings are in agreement with the previous reports on
antihyperglycemic properties of other Thymus species
(Benkhayal et al., 2010b; Kabbaoui et al., 2016; Shewasinad
et al., 2018). In this sense, the antihyperglycemic properties of
the aqueous extract and essential oil of the plant may be related to
the presence of high concentration plant secondary metabolites,
especially phenolic acids and other polyphenols (in the aqueous
extract), and isomeric phenolic monoterpenes thymol and
carvacrol in the essential oil (Çam et al., 2017).
Mice with severe hyperglycemia tend to lose a large percentage
of their weight after injection of STZ (Ye, et al., 2011). The
aqueous extract and essential oil at 600 mg/kg dose level
significantly prevented weight loss in mice (−1.96% and
−2.65%, respectively) comparable to glibenclamide (−1.25%).
Similar findings were also observed on the aqueous leaf extract
of T. satureioides at 500 mg/kg body weight (Kabbaoui et al.,
2016). Some studies suggest that increase in body weight could be
attributed to the protective effect of the plant extract against
degradation of structural proteins, lipids, and muscle wasting,
possibly due to improvement of glycemic control via
enhancement of insulin secretion or/and action (Kumar et al.,
2014; Emiru et al., 2020).
Regarding the in vitro carbohydrate digestive enzyme
inhibitory studies, the essential oil showed potent α-amylase
inhibitory activity (IC50  0.01 ± 0.00 mg/ml) as compared to
the antidiabetic drug acarbose (IC50  0.05 ± 0.02 mg/ml) and the
aqueous extract (IC50  24.47 ± 0.29 mg/ml). Likewise, the
essential oil also demonstrated the highest α-glucosidase
inhibitory (IC50  0.11 ± 0.01 mg/ml) activity. Previous studies
showed a similar trend in terms of α-glucosidase inhibitory
activity of T. albicans, T. carnosus and T. mastichina essential
oils (Aazza et al., 2016). On the other hand, the aqueous extract
revealed better inhibitory activity against α-glucosidase (about
10 times greater) than the α-amylase inhibitory activity.
Therefore, the antihyperglycemic effect of the aqueous extract
could be partly associated with its ability to inhibit α-glucosidase,
which delays the postprandial rise in blood glucose by retarding
the digestion of carbohydrate (Al-Hajj et al., 2016). A more
effective digestive enzyme inhibitor is expected when it shows
mild inhibitory activity for α-amylase but strongly inhibit
α-glucosidase enzyme as intestinal disorders such as diarrhea,
abdominal pain, and flatulence occur as result of complete
inhibition of α-amylase enzyme. This occurs because the
starch undigested by the enzyme is used by the intestinal
microflora, resulting in gas formation (Cho et al., 2011). These
are important findings open up a possibility of the hypoglycemic
activity of T. serrulatus to control postprandial hyperglycemia via
the inhibition carbohydrate digestive enzymes that offer an
attractive strategy by delaying glucose absorption and which
can potentially slow down the progression of diabetes.
It is argued that postprandial plasma glucose level is more
reflective of glucose control than fasting plasma glucose, thus this
may be more useful for monitoring diabetic patients (Shahram
and Nargess, 2008; Min Park et al., 2009; Lim et al., 2017). The
elevated postprandial glucose level is considered an independent
risk factor for the development of macrovascular complications
associated with diabetes and impaired glucose tolerance. It is also
been linked with cardiovascular complications despite the HbA1c
values being in the non-diabetic range (Aravind et al., 2015).
Oxidative stress results from an increased level of reactive
oxygen species in the body, which are believed to be involved
in the pathogenesis of diabetes (Kaneto et al., 2010). Hence,
phytochemicals with antioxidant activity can play a significant
role in the treatment of diabetes related disorders (Catarino et al.,
2015). Another approach to treat hyperglycemic condition is to use
drugs that lower the glucose absorption by competitively inhibiting
intestinal carbohydrate hydrolyzing enzymes and to decrease
inflammatory conditions involved in the pathology of type 2
diabetes (Ota and Ulrih, 2017). Further, the phytochemicals
present in the plant may also have the properties to increase
secretion of insulin by stimulating or regenerating the β-cells of
islets of Langerhans, which may finally improve the activity of
carbohydrate metabolizing enzymes toward the re-
establishment of normal BGL (Oh, 2015). For instance,
phenolic acids like rosmarinic acid, one of the main
components of the aqueous extract, is proven to enhance
glucose utilization and insulin sensitivity beyond its
antioxidant activity (Runtuwene et al., 2016). The
antidiabetic prospective associated with flavones including
apigenin and luteolin glycosides are known to enhance
insulin action, augment the expression and transcriptional
activation of PPARγ (peroxisome proliferator-activated receptor
gamma) target genes, reduce oxidative stress and inflammation in
muscle and promote translocation of GLUT4 (Hossain et al., 2016).
Although the antidiabetic effect of thymol and its underlying
mechanism of action needs to be furthered explored, it has
potential as an anti-hyperglycemic agent by improving insulin
resistance in diabetic mice (Saravanan and Pari, 2015).
Hyperglycemia induced oxidative stress via mitochondrial
electron-transport chain and subsequent activation of the
inflammatory response are considered to be major contributor
to diabetes related disorders (Santilli et al., 2015). Therefore,
Frontiers in Pharmacology | www.frontiersin.org April 2021 | Volume 12 | Article 62153611
Haile et al. Thymus Serrulatus: Chemistry and Bioactivity
phenolic compounds such as phenolic acids and flavonoids, as
antioxidants, have a beneficial role in preventing and improving
vascular diabetic complications (Aryaeian et al., 2017) and
enhance diabetic wound healing process (Thent and Latiff,
2017). Phytochemicals with antioxidant activity were also
proven to revert atherosclerotic cardiovascular complications
such as coronary artery diseases by reducing the elevated
serum lipid levels in diabetic patients (Bacanli et al., 2019;
Hirano, 2018).
CONCLUSION
In conclusion, this study suggested that both the aqueous extract
and essential oil of T. serrulatus have potential antioxidant
scavenging ability. Moreover, the two T. serrulatus samples hold
potency to inhibit α-amylase and α-glucosidase enzymes, which are
key metabolic enzymes and targets for diabetes treatment. In
addition, the results also demonstrated that T. serrulatus was
capable of inducing significant antihyperglycemic activities in
normoglycemic and STZ induced diabetic mice, as well as of
effectively preventing the anticipated body weight loss of the
diabetic mice. The overall results suggest that the presence of
phenolic constituents in the test samples increased the blood
glucose lowering effects of T. serrulatus, although further
analysis using specific metabolites of these compounds must be
tested in order to consolidate such theory. Note also that although
the extract and essential oil showed strong radical scavenging
activity in different chemical assays, their effectiveness still
needs to be evaluated in animal models. We also recommend
further investigation to evaluate the anti-diabetic effect of the plant
extract and essential oil at lower dose levels to translate the effect
closer to a therapeutic value for human studies.
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